These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4074910)

  • 1. [Prostatic carcinoma: histoprognosis, prognostic value of Gleason's index].
    Saint-André JP; Rousselet MC; Six P; Bertrand G; Soret JY
    Bull Cancer; 1985; 72(5):414-22. PubMed ID: 4074910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reproducibility and prognostic value of Gleason's and Gaeta's histological grades in prostatic carcinoma].
    Rousselet MC; Saint-André JP; Six P; Soret JY
    Ann Urol (Paris); 1986; 20(5):317-22. PubMed ID: 3777875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
    Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
    Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology.
    Vesalainen S; Lipponen P; Nordling S; Talja M; Syrjänen K
    Anticancer Res; 1995; 15(2):569-73. PubMed ID: 7763039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour.
    Lipponen P; Vesalainen S; Kasurinen J; Ala-Opas M; Syrjänen K
    Anticancer Res; 1996; 16(4A):2095-100. PubMed ID: 8712749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma.
    Vesalainen S; Lipponen P; Talja M; Alhava E; Syrjänen K
    Anticancer Res; 1994; 14(2B):709-14. PubMed ID: 8010731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
    Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
    Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.
    Tsihlias J; Kapusta LR; DeBoer G; Morava-Protzner I; Zbieranowski I; Bhattacharya N; Catzavelos GC; Klotz LH; Slingerland JM
    Cancer Res; 1998 Feb; 58(3):542-8. PubMed ID: 9458103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between histological grading and the prognosis of prostatic carcinoma--a comparative study of the Japanese General Rules of Prostatic Cancer (JGRPC) and Gleason's classification].
    Uchida T; Go M; Nakajo H; Takagi Y; Murayama M; Honda N; Igarashi M; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1988 Jan; 34(1):116-22. PubMed ID: 3376792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiologic indicators of adenocarcinoma of the prostate. Results on 436 patients].
    Arrizabalaga Moreno M; García González JI; Diez Rodríguez JM; Esteban Artiaga R; Castro Pita M; Navarro Sebastian J; Mora Durbán M; Paniagua Andrés P
    Actas Urol Esp; 1997 Oct; 21(9):852-61. PubMed ID: 9471868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis].
    Kumamoto Y; Tsukamoto T; Umehara T; Harada M; Shimazaki J; Fuse H; Oshima H; Takeuchi H; Yoshida O; Okada K
    Hinyokika Kiyo; 1990 Mar; 36(3):295-305. PubMed ID: 2191571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of prostatic intraepithelial neoplasia and adenocarcinoma of the prostate: prognostic influences of stage, tumor volume, grade, and margins of resection.
    Epstein JI
    Semin Oncol; 1994 Oct; 21(5):527-41. PubMed ID: 7939746
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oncologic after-care of patients with prostate cancer].
    Friedrich A; Glass W
    Z Urol Nephrol; 1986 Apr; 79(5):269-75. PubMed ID: 2426869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical assessments on pre-treatment prognostic factors in 138 patients with advanced prostatic carcinoma (stage D2)].
    Kato M; Okada K; Yamashina M; Tohma T; Ishiwata D; Higashi Y; Ohwada F
    Hinyokika Kiyo; 1993 Feb; 39(2):131-4. PubMed ID: 8465686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden.
    Andrén O; Fall K; Franzén L; Andersson SO; Johansson JE; Rubin MA
    J Urol; 2006 Apr; 175(4):1337-40. PubMed ID: 16515993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.